Supplement NDI Draft Guidance Discussions Snagged On Basic Criteria
This article was originally published in The Tan Sheet
Executive Summary
FDA’s dietary supplement division is concerned that firms are not submitting NDI notifications in cases where they should be, while industry stakeholders assert the agency needs to clarify the criteria for determining which products should be the subject of notifications and what information is needed.